The New ADA 2026 Diabetes Screening Guidelines: Who Should Be Tested Earlier?

July 8, 2026

| Edited By: HealthSpectra Editorial Team

In this Article

The New ADA 2026 Diabetes Screening Guidelines — Src

When Marcus, a 32-year-old graphic designer in Atlanta, mentioned at a routine physical that his father had been diagnosed with type 2 diabetes in his late forties, his doctor paused and pulled up the latest screening guidelines.

Even though Marcus felt healthy and his weight was only modestly above normal, his combination of family history, sedentary work, and slightly elevated blood pressure pushed him into a category that now warrants earlier testing.

That conversation captures the spirit of the ADA 2026 diabetes screening guidelines. The American Diabetes Association continues to shift screening earlier and make it more personalized, because type 2 diabetes and prediabetes are increasingly showing up in adults under 45, and even in adolescents.

Identifying elevated blood sugar before complications develop opens a window where lifestyle changes, monitoring, and treatment can meaningfully alter the trajectory of the disease.

The Short Version

The ADA 2026 Standards of Care reaffirm routine diabetes screening starting at age 35 for most adults, with earlier risk-based screening for those who carry additional risk factors.
Family history, overweight or obesity, hypertension, abnormal cholesterol, PCOS, prior gestational diabetes, and certain ethnic backgrounds all trigger earlier testing.
Children and adolescents who are overweight or obese plus have at least one other risk factor should be screened starting at age 10 or at puberty onset.
A1C, fasting plasma glucose, and the oral glucose tolerance test remain the three primary screening tools, with autoantibody testing now recommended for relatives of people with type 1 diabetes.

Why Earlier Diabetes Screening Matters

Rates of obesity and metabolic dysfunction have climbed across all age groups, and so has diabetes incidence in people younger than 45. According to the 2026 CDC National Diabetes Statistics Report, an estimated 40.1 million Americans now live with diabetes and another 115.2 million have prediabetes, many of whom remain undiagnosed for years.

“The 2026 ‘Standards of Care in Diabetes’ represents a significant advancement in the delivery of evidence-based, person-centered care,” said Dr. Rita Kalyani, the ADA’s chief scientific and medical officer and a professor of medicine at Johns Hopkins. The shift toward earlier screening reflects two decades of evidence that early detection changes outcomes.

The landmark SEARCH for Diabetes in Youth study, published in the New England Journal of Medicine, reported an average annual increase of 4.8 percent in newly diagnosed type 2 diabetes cases in U.S. youth between 2002 and 2012, with sharper rises among Hispanic, Black, and Asian American adolescents. A follow-up MMWR analysis from the CDC extended the data through 2015 and confirmed steady increases in both type 1 and type 2 diabetes among American youth, particularly in minority populations.

Type 2 diabetes typically develops gradually. Blood sugar climbs slowly while the pancreas compensates with extra insulin, so symptoms may not appear until significant beta cell function is already lost. By the time classic signs like excessive thirst, fatigue, or blurred vision show up, many people already have small vessel damage in the eyes, kidneys, or nerves.

Detecting prediabetes or early type 2 diabetes creates time for structured lifestyle change before vascular damage accumulates. Evidence from the Diabetes Prevention Program shows that a five to seven percent reduction in body weight, combined with regular physical activity, cuts progression from prediabetes to type 2 diabetes by roughly 58 percent. Earlier screening simply expands the population that can benefit.

What the ADA 2026 Guidelines Say About Diabetes Screening

The 2026 ADA Standards of Care in Diabetes, published in the January 2026 supplement of Diabetes Care, lay out a clear framework that emphasizes risk-based testing alongside age-based defaults.

For adults without known risk factors, screening is recommended starting at age 35 and should be repeated at least every three years if results are normal. The ADA notes that the testing interval may shorten when results sit near the diagnostic threshold or when risk factors accumulate over time.

Adults of any age who are overweight or obese (BMI of 25 or higher, or 23 or higher in Asian American populations) should be screened when they have one or more additional risk factors.

Asian Americans face higher metabolic risk at lower body weights because they tend to accumulate fat around the abdominal organs rather than under the skin, a pattern that drives insulin resistance even when overall body weight looks normal. This is why the ADA uses a lower BMI threshold for this group.

The 2026 update continues a trend the ADA started several years ago: instead of relying only on age, the guidelines now factor in BMI, ethnicity, comorbidities, reproductive history, and stage of life. Behavioral health and sleep also enter the picture, since both affect glucose regulation and overall risk.

Who Should Be Tested for Diabetes Earlier?

Knowing who is at risk for diabetes is the first step in deciding when to test. The 2026 guidelines recognize that risk factors typically cluster, and two or more should trigger evaluation regardless of age.

For adults with a BMI at or above the cutoff, the ADA recommends earlier screening when any of the following are present: physical inactivity, hypertension (blood pressure of 130/80 mm Hg or higher, or currently on therapy), HDL cholesterol below 35 mg/dL or triglycerides above 250 mg/dL, a history of cardiovascular disease, or a history of gestational diabetes.

Gestational diabetes is a form of high blood sugar that develops during pregnancy and typically resolves after delivery. Women who have had it face up to a 50 percent lifetime risk of developing type 2 diabetes, which is why prior gestational diabetes remains one of the most significant screening triggers.

A first-degree relative with diabetes substantially raises the risk regardless of weight. Genetics influences insulin secretion, fat distribution, and metabolic response to diet, so two people eating the same way can have very different outcomes.

The ADA explicitly lists African American, Hispanic/Latino, Native American, Asian American, and Pacific Islander populations as having elevated risk for type 2 diabetes at lower BMI thresholds. This recognition is not about predetermined fate but about adjusting screening so the disease is caught at the same stage across populations.

Polycystic ovary syndrome involves chronic insulin resistance, and more than half of women with PCOS develop type 2 diabetes by age 40. Metabolic syndrome, defined by a cluster of abdominal obesity, high blood pressure, elevated triglycerides, low HDL, and elevated fasting glucose, similarly raises risk and warrants earlier testing.

Anyone who has previously screened in the prediabetes range (an A1C of 5.7 to 6.4 percent, a fasting glucose of 100 to 125 mg/dL, or a two-hour OGTT of 140 to 199 mg/dL) should be retested annually. Progression from prediabetes to diabetes is common without intervention, but it is far from inevitable when lifestyle changes are sustained.

Diabetes Screening in Children and Adolescents

Pediatric type 2 diabetes was almost unheard of three decades ago. Today it accounts for a meaningful share of new pediatric diagnoses, and the ADA has built risk-based pediatric screening into its standards. Youth-onset disease tends to progress faster than adult-onset diabetes and is associated with earlier complications, which makes catching it early especially important.

The ADA recommends screening for children and adolescents who are overweight (BMI at or above the 85th percentile) or obese (95th percentile), starting at age 10 or at the onset of puberty, whichever comes first, when at least one additional risk factor is present. Testing repeats every three years if the results are normal.

Pediatric risk factors include a mother with diabetes or gestational diabetes during the child’s pregnancy, family history of type 2 diabetes in a first- or second-degree relative, certain race or ethnicity, and signs of insulin resistance. Those signs include acanthosis nigricans, polycystic ovary syndrome, hypertension, or dyslipidemia.

Acanthosis nigricans appears as dark, velvety patches of skin, most often on the back of the neck or in the armpits. Parents who notice this discoloration on their child should bring it up at the next pediatric visit, as it can signal underlying insulin resistance.

What Tests Are Used to Screen for Diabetes?

Three tests dominate the screening landscape, each with slightly different strengths.

Blood Sugar Guidelines

Diabetes & Prediabetes Diagnostic Thresholds

Test	What It Measures	Diabetes Threshold	Prediabetes Range
Hemoglobin A1C test	Average blood sugar levels over the past 2–3 months	≥6.5%	5.7–6.4%
Fasting Plasma Glucose test	Blood sugar level after an 8-hour fast	≥126 mg/dL	100–125 mg/dL
Oral Glucose Tolerance Test	Blood sugar level 2 hours after consuming a 75 g glucose drink	≥200 mg/dL	140–199 mg/dL

Any abnormal result usually needs confirmation with a second test on a different day before a formal diagnosis is made.

A1C Test

The hemoglobin A1C test reflects average blood sugar over the prior two to three months by measuring the percentage of red blood cells with glucose attached. It does not require fasting and fits easily into a routine primary care visit. Certain conditions, including sickle cell trait, pregnancy, recent blood loss, and chronic kidney disease, can distort the result.

Fasting Plasma Glucose Test

A fasting plasma glucose test requires no eating or drinking (except water) for at least eight hours. It is inexpensive and widely available, though results can vary day to day based on stress, sleep, and recent illness.

Oral Glucose Tolerance Test

The OGTT measures blood glucose before and two hours after drinking a standardized 75-gram glucose solution. It is more sensitive for detecting prediabetes but takes more time and requires tolerating a sugary drink. It is the preferred test during pregnancy.

Why Doctors May Choose One Test Over Another

Clinicians often select based on convenience, the patient’s health context, and the specific risk profile. Some people screen normal on A1C but show prediabetes on the OGTT, so combining tests can be valuable when risk is high, or results sit on the edge.

Prediabetes Screening: Why It’s a Major Focus

Prediabetes is the stage where blood sugar is elevated but not yet in the diabetes range. Roughly one in three U.S. adults has prediabetes, and most do not know it.

People with prediabetes typically feel fine. There are no clear symptoms, and standard non-fasting blood panels may not catch it. That invisibility is why the ADA emphasizes proactive screening rather than waiting for symptoms.

The ADA 2026 prevention guidance emphasizes structured lifestyle intervention as first-line therapy for prediabetes.

That means roughly 150 minutes per week of moderate physical activity, a Mediterranean-style or low-carbohydrate eating pattern, and a target weight loss of 5 to 7 percent for those who are overweight. Metformin may be added in selected higher-risk individuals.

Type 1 Diabetes Screening: What’s New?

For most of medical history, type 1 diabetes was diagnosed only when symptoms appeared, often dramatically as diabetic ketoacidosis. The 2026 standards continue a recent shift toward identifying early-stage type 1 diabetes through autoantibody testing.

Type 1 diabetes now has recognized presymptomatic stages. Stage 1 is defined by the presence of two or more diabetes-related autoantibodies with normal blood sugar. Stage 2 includes those same antibodies plus dysglycemia, and Stage 3 is clinical diabetes.

“We know that type 1 diabetes develops over a period of years,” explained Dr. Kevan Herold, professor of immunobiology and internal medicine at Yale and chair of Type 1 Diabetes TrialNet. Identifying the disease at an early stage allows monitoring, education, and, in some cases, treatment.

Teplizumab (brand name Tzield), an FDA-approved injectable approved in 2022, works by calming the immune cells that attack insulin-producing cells in the pancreas. In eligible patients with Stage 2 type 1 diabetes, it has been shown to delay progression to clinical diabetes by about two years on average. Programs such as TrialNet offer free autoantibody screening for eligible family members.

The ADA recommends autoantibody screening primarily for first-degree relatives of people with type 1 diabetes, since their risk is about 15 times higher than the general population. Population-wide screening is not yet standard because the general population carries a relatively low absolute risk, and false positives can cause unnecessary anxiety.

Symptoms That Should Prompt Diabetes Testing Regardless of Age

Even with stronger screening guidelines, classic symptoms always warrant testing regardless of risk profile.

Common warning signs include increased thirst, frequent urination (especially at night), unexplained weight loss, persistent fatigue, blurry vision, slow-healing wounds, and recurrent infections such as yeast infections or urinary tract infections. In younger adults and adolescents, these symptoms are sometimes dismissed as stress or growth-related, and shouldn’t be.

Dr. Dana Dabelea, Conrad M. Riley Distinguished Professor at the Colorado School of Public Health and co-leader of the SEARCH study, has emphasized that the yearly rate of newly diagnosed cases of both Type 1 and Type 2 diabetes in youth increased significantly over the past two decades, making symptom awareness in younger populations more important than ever.

How Often Should Diabetes Screening Be Repeated?

For adults with normal results and no significant risk factors, the ADA recommends retesting at least every three years. People with prediabetes should be retested annually, and those with multiple risk factors or recent weight gain may need more frequent testing as their physician judges appropriate.

Other situations that may justify more frequent testing include initiation of medications that raise blood sugar (such as glucocorticoids or certain antipsychotics), pregnancy planning in women with prior gestational diabetes, and significant changes in lifestyle or weight.

Lifestyle Changes Recommended After Early Detection

Early detection only matters if it leads to action. The good news is that the same interventions work whether someone has prediabetes, newly diagnosed type 2 diabetes, or simply wants to lower future risk.

Regular movement improves how cells respond to insulin and can lower A1C within months. The ADA recommends at least 150 minutes per week of moderate aerobic activity, plus two sessions of resistance training. Walking after meals is one of the simplest ways to reduce post-meal blood glucose spikes.

Mediterranean-style eating, the DASH pattern, and lower-carbohydrate approaches all show benefit for blood sugar management. The common thread: plenty of vegetables, legumes, whole grains, lean proteins, and healthy fats, with reduced sugary beverages, refined grains, and ultra-processed foods.

Chronic sleep deprivation and high stress raise cortisol, which in turn raises blood sugar and blood pressure. The 2026 ADA standards explicitly recommend sleep health screening for people with diabetes and those at risk, recognizing how tightly sleep and metabolism are linked. Acting early may also prevent the vascular changes that contribute to heart disease and kidney damage.

Questions to Ask Your Doctor About Diabetes Screening

Walking into a screening appointment with clear questions tends to produce better outcomes. Useful ones include:

Am I at increased risk for diabetes based on my history and family background?
Which screening test is most appropriate for me, and should I do more than one?
How often should I be tested, given my current health?
What specific changes would have the biggest impact on my future diabetes risk?
Does my insurance cover diabetes screening, including A1C testing, as part of preventive care? Many plans cover it at no cost, but confirming in advance helps avoid surprise bills.

Before your appointment, you can also take the ADA’s free 60-second Type 2 Diabetes Risk Test at diabetes.org. It takes about a minute and gives you a sense of your risk level before you even walk in the door.

Conclusion

The ADA 2026 diabetes screening guidelines reflect a clear direction in modern diabetes care: catch elevated blood sugar earlier, screen more thoughtfully, and tailor testing to individual risk rather than relying only on age. With diabetes increasingly affecting younger adults and adolescents, this shift toward personalized, risk-based screening is timely.

For most adults, the new standard is straightforward. Begin screening at age 35, screen earlier if you carry additional risk factors, retest at intervals appropriate to your risk, and treat any abnormal result as an opening for action rather than a sentence. The ADA 2026 diabetes screening guidelines reward people who engage with their own risk profile.

If you have not been screened for diabetes recently, or if you have risk factors you have not discussed with a clinician, this is a reasonable time to bring it up. Earlier identification of prediabetes or diabetes creates the most options, and those options translate into better long-term metabolic health.

References